Achieving patient centricity: 4 key lessons from orphan disease companies

Orphan drugs – leading the way in patient centricity

The need to increase patient centricity in pharma is currently a hot topic in the industry, but in the orphan drug / rare disease space it has been a reality for many years.

Read the latest article from Executive Insight and learn the 4 key lessons that are crucial for true patient engagement!